B6(Cg)-Gata1tm(avi) Tg(Hnrnpa2b1/Cbx1-birA)1Jstr/Flmg

Status

Under development - register interest

EMMA IDEM:15433
International strain nameB6(Cg)-Gata1tm(avi) Tg(Hnrnpa2b1/Cbx1-birA)1Jstr/Flmg
Alternative nameAviGata1short/BirA
Strain typeTransgenic Strains
Allele/Transgene symbolhnRNPA2/CBX- 3xHABirA
Gene/Transgene symbolhnRNPA2/CBX- 3xHABirA

Information from provider

ProviderJohn Strouboulis
Provider affiliationSchool of Cancer and Pharmaceutical Sciences, King
Additional ownerProfessor Paresh Vyas, Oxford University, Radcliffe Department of Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom
Genetic informationMice carry a targeted X-linked Gata1 gene mutation such that the second exon is removed and replaced by an in-frame fusion of the short (14 aa) biotinylatable Avi tag. In this way, the mouse expresses an Avi-tagged, N-terminally truncated mutant of GATA1, called GATA1short. The mouse strain is also transgenic for the BirA bacterial biotin ligase under the control of the hnRNPA2 promoter (see description under EMMA strain ID EM:09008). As a result, this mouse strain expresses in vivo biotinylated GATA1short protein in tissues where the Gata1 gene is normally active (mainly erythroid cells and megakaryocytes).
Phenotypic informationHomozygous:
Embryos homozygous for the targeted GATA1short deletion present with a transient expansion of megakaryocytes with impaired erythropoiesis around E11.5-E14.5. Impaired erythropoiesis results in transient anemia which is lethal in utero for 10-15% of the embryos (mostly male; Gata1 is an X-linked gene). In adult mice, bone marrow erythropoiesis is perturbed with delayed maturation of erythroid cells. A slightly enlarged spleen with erythropoietic activity. Overall, a mild phenotype. No phenotype observed in mice transgenic for the 3xHA BirA/hnRNPA2-CBX transgene.

Heterozygous:
None. For male mice, see above.
Breeding historyThis mouse strain has been continuously bred for the last 8 years or so.
ReferencesNone available
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreB.S.R.C. Alexander Fleming, Vari, Greece

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching


Information on how we integrate external resources can be found here

Register interest

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).